HWAM
Hennion & Walsh Asset Management’s Nektar Therapeutics NKTR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-73,313
| Closed | -$43.7K | – | 849 |
|
|
2023
Q3 | $43.7K | Sell |
73,313
-14,473
| -16% | -$8.62K | ﹤0.01% | 797 |
|
|
2023
Q2 | $50K | Buy |
87,786
+924
| +1% | +$526 | ﹤0.01% | 796 |
|
|
2023
Q1 | $61K | Sell |
86,862
-2,042
| -2% | -$1.43K | ﹤0.01% | 769 |
|
|
2022
Q4 | $201K | Sell |
88,904
-134,143
| -60% | -$303K | 0.01% | 731 |
|
|
2022
Q3 | $714K | Sell |
223,047
-10,721
| -5% | -$34.3K | 0.05% | 405 |
|
|
2022
Q2 | $888K | Sell |
233,768
-95,540
| -29% | -$363K | 0.06% | 345 |
|
|
2022
Q1 | $1.78M | Buy |
329,308
+19,676
| +6% | +$106K | 0.09% | 239 |
|
|
2021
Q4 | $4.18M | Buy |
309,632
+25,020
| +9% | +$338K | 0.21% | 131 |
|
|
2021
Q3 | $5.11M | Sell |
284,612
-9,242
| -3% | -$166K | 0.27% | 96 |
|
|
2021
Q2 | $5.04M | Buy |
293,854
+29,153
| +11% | +$500K | 0.27% | 91 |
|
|
2021
Q1 | $5.29M | Buy |
+264,701
| New | +$5.29M | 0.32% | 78 |
|